Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

ARS Pharmaceuticals (SPRY) Asset Utilization Ratio (2022 - 2025)

ARS Pharmaceuticals' Asset Utilization Ratio history spans 4 years, with the latest figure at 0.24 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 23.24% year-over-year to 0.24; the TTM value through Dec 2025 reached 0.24, down 23.24%, while the annual FY2025 figure was 0.25, 18.62% down from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.24 at ARS Pharmaceuticals, down from 0.42 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.42 in Q3 2025 and bottomed at 0.0 in Q1 2024.
  • The 4-year median for Asset Utilization Ratio is 0.0 (2022), against an average of 0.1.
  • The largest annual shift saw Asset Utilization Ratio plummeted 98.22% in 2024 before it surged 659486.06% in 2025.
  • A 4-year view of Asset Utilization Ratio shows it stood at 0.0 in 2022, then crashed by 97.39% to 0.0 in 2023, then soared by 251602.23% to 0.31 in 2024, then decreased by 23.24% to 0.24 in 2025.
  • Per Business Quant, the three most recent readings for SPRY's Asset Utilization Ratio are 0.24 (Q4 2025), 0.42 (Q3 2025), and 0.35 (Q2 2025).